GROWTH STOCKS News & Analysis

Tesla’s current product lineup may have reached market saturation. But investors have high hopes its robotaxi business.

This healthcare company still has plenty of growth potential, but it’s been a rocky road for investors recently.

Cochlear’s biggest market segment has matured and it is looking elsewhere for growth.

Monster's share price is up over 18 times since I first came across its products in the late noughties. What can we learn from its rise?

In the life insurance software industry, growth requires patience. Shaun Ler thinks this ASX listed firm is positioned to win.

WiseTech’s latest acquisition is bigger than its previous 55 combined. Integration could be challenging but the timing looks right.

WiseTech’s competitive position is incredibly strong and looks set to underpin formidable sales growth for the foreseeable future.

And our equity analysts’ outlook for the stocks.

Niche play with more growth potential than many investors give it credit for.

Shares in the streaming giant don’t look especially cheap, even if management achieves its ambitious goals for 2030.